114779-46-3Relevant articles and documents
N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED TRP-PHE- AND PHENETHYLAMINE DERIVATIVES
-
, (2008/06/13)
Novel unnatural dipeptoids of α-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further the compounds are antianxiety agents, antiulcer agents, antidepressant agents, and are agents useful for preventing the withdrawal response produced by chronic treatment or use followed by chronic treatment followed by withdrawal from nicotine, diazepam, alcohol, cocaine, caffeine, or opiods. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare pharmaceutical and diagnostic compositions.
α-Methyl tryptophanylphenylalanines and their arylethylamine 'dipeptoid' analogues of the tetrapeptide cholecystokinin (30-33)
Horwell,Birchmore,Boden,Higginbottom,Ping Ho,Hughes,Hunter,Richardson
, p. 53 - 60 (2007/10/02)
A series of N-alkyl carbamate blocked α-Me-Trp-Phe and α-Me-Trp-phenethylamides has been identified as 'dipeptoid' analogues of CCK-4 (CCK 30-33). These compounds have micromolar affinity for the type-B central CCK receptor, some of which increase the fir